TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00796718 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT02157311 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01115608 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04330651 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT04402697 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00484692 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT03556761 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03115164 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT03115164 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT04465292 — Predictive Biomarker (PRD): COL17A1 mRNA
Genes: COL17A1; BP180; BPAG2
Study NCT03139344 — Predictive Biomarker (PRD): NR4A3 mRNA
Genes: NR4A3; CHN; CSMF; MINOR; NOR1; TEC
Study NCT03139344 — Predictive Biomarker (PRD): PPARGC1B mRNA
Genes: PPARGC1B; PERC; PGC1; PGC1B; PPARGC1
Study NCT03139344 — Predictive Biomarker (PRD): PDK4 mRNA
Genes: PDK4; PDHK4
Study NCT03139344 — Predictive Biomarker (PRD): MYH6 mRNA
Genes: MYH6; MYHCA
Study NCT03139344 — Predictive Biomarker (PRD): MYL3 mRNA
Genes: MYL3
Study NCT03139344 — Predictive Biomarker (PRD): MYH7 mRNA
Genes: MYH7; MYHCB
Study NCT03139344 — Predictive Biomarker (PRD): ACTN3 mRNA
Genes: ACTN3
Study NCT04367207 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03540199 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT00598312 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01309698 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00186901 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04461834 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01872117 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02504645 — Predictive Biomarker (PRD): IPP mRNA
Genes: IPP; KLHL27
Study NCT00967343 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01489332 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT00104767 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT01760356 — Predictive Biomarker (PRD): NFATC2 mRNA
Genes: NFATC2; NFAT1; NFATP
Study NCT01760356 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01760356 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT02291666 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT02291666 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT02291666 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02291666 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02291666 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT02291666 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02291666 — Predictive Biomarker (PRD): CYP2E1 mRNA
Genes: CYP2E1; CYP2E
Study NCT04646850 — Predictive Biomarker (PRD): SLC2A1 mRNA
Genes: SLC2A1; GLUT1
Study NCT02984254 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00554372 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02171741 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02171741 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04718246 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02824068 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03734419 — Predictive Biomarker (PRD): ELOVL2 mRNA
Genes: ELOVL2; ELG3; SSC2
Study NCT03659136 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03659136 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03316651 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04410432 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT01573702 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01573702 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03033368 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02013765 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01070004 — Predictive Biomarker (PRD): PER3 mRNA
Genes: PER3; GIG13
Study NCT01070004 — Predictive Biomarker (PRD): ADORA2A mRNA
Genes: ADORA2A; ADORA2
Study NCT03876106 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03876106 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02498340 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT00837343 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT00837343 — Safety Biomarker (SAF): BDNF
Study NCT02253485 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01161537 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04399213 — Pharmacodynamic Biomarker (PDY): Dermal blood flow
Study NCT00669500 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00984893 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04411472 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04286815 — Predictive Biomarker (PRD): IL2RG mRNA
Genes: IL2RG
Study NCT03346772 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03378674 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT04531345 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04531345 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02983188 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02983188 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02983188 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02983188 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01902849 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01902849 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01488383 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02783599 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT02479815 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02286635 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03972878 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03972878 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT03972878 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04006821 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT01167660 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT03962127 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02923076 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT04052594 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00151476 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT02029885 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01590602 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT01294722 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02188654 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00418327 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00468351 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01729806 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00687271 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03828097 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02080403 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT02110797 — Predictive Biomarker (PRD): MECP2 mRNA
Genes: MECP2
Study NCT02110797 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT02130505 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT02812992 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT06119347 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04351724 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT04351724 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04351724 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03358134 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT03587337 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT03587337 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03587337 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT03938350 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03067441 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05312528 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05312528 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05312528 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02695550 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02695550 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study NCT02414009 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT00968305 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT00285168 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01054625 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00673608 — Predictive Biomarker (PRD): Liver iron
Study NCT02289144 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02806739 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03652363 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study NCT03652363 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00119821 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00863135 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03727802 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study NCT00003289 — Predictive Biomarker (PRD): UCN mRNA
Genes: UCN
Study NCT00755729 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00755729 — Predictive Biomarker (PRD): PIR mRNA
Genes: PIR
Study NCT00755729 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study NCT02701829 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00935441 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00198042 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00360646 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT04538079 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03292445 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03292445 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00227045 — Predictive Biomarker (PRD): MFF mRNA
Genes: MFF; C2orf33; AD030; AD033; GL004
Study NCT04157322 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT01417455 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03408301 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03922022 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03019133 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04541836 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02890381 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00998933 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT00558181 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03702829 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT02906020 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT03943394 — Predictive Biomarker (PRD): PCM1 mRNA
Genes: PCM1
Study NCT03943394 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT04619563 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04619563 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT03607383 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01744236 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00113035 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT03790891 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03412734 — Surrogate Endpoint (SUR): Bacterial count
Study NCT04488302 — Predictive Biomarker (PRD): FBL mRNA
Genes: FBL; FIB1; FLRN
Study NCT05227781 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study NCT05227781 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00006411 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT01814345 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01882439 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03314532 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT04269629 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03234946 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03710460 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT01223664 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04354870 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02676843 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00872586 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03865212 — Predictive Biomarker (PRD): TYRP1 mRNA
Genes: TYRP1; CAS2; TYRP; TYRRP
Study NCT00931073 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00931073 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00931073 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00647920 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00475826 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT02247843 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02247843 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00579527 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00302224 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01640301 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT01283789 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01776151 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00796172 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00792324 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03214068 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT04353206 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02722811 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02722811 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study NCT02722811 — Predictive Biomarker (PRD): MMP13 mRNA
Genes: MMP13
Study NCT02722811 — Safety Biomarker (SAF): Interleukin 1
Study NCT01300572 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT01791478 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01791478 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02883101 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01600937 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01674205 — Predictive Biomarker (PRD): PYCARD mRNA
Genes: PYCARD; ASC; CARD5; TMS1
Study NCT01674205 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01347996 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02006849 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT02006849 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study NCT01368081 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00909532 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00078715 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01130168 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03783169 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04362358 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04712448 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT00827398 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01148433 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01302535 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01038232 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00808132 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03267225 — Predictive Biomarker (PRD): NR1I2
Genes: ONR1; PXR; BXR; SXR; PAR2
Study NCT01726985 — Surrogate Endpoint (SUR): Serum sodium
Study NCT03869606 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02461862 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01209598 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT01791413 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00299806 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03508609 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT03508609 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00521976 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT00521976 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00426842 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01602367 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02366156 — Predictive Biomarker (PRD): DGAT1 mRNA
Genes: DGAT1; AGRP1; DGAT
Study NCT00005151 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00432770 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04059120 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04059120 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02020317 — Surrogate Endpoint (SUR): Serum potassium
Study NCT00151723 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03931577 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02725541 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02650102 — Safety Biomarker (SAF): miR-30e
Genes: MIR30E
Study NCT01408459 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01151215 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03463551 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01462396 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02990676 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT04371601 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03767751 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT03767751 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT00160277 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03850275 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04337671 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03013140 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04105075 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04105075 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01126697 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01126697 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT02092025 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04355936 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT03459976 — Predictive Biomarker (PRD): WAP four-disulfide core domain protein 2
Genes: WFDC2; HE4; WAP5
Study NCT00616967 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02350660 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT01037309 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00741442 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT00259753 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01594905 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00724386 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT02256124 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02653209 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02653209 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05144399 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1